The FactView Typhoid IgG/IgM Rapid Test Kit is a diagnostic assay used for the qualitative detection of IgG and IgM antibodies specific to Salmonella typhi, the bacterium that causes typhoid fever. Here's more information about this type of diagnostic test:
Purpose: The test is used for the rapid diagnosis of typhoid fever, a bacterial infection caused by Salmonella typhi. Typhoid fever is characterized by fever, abdominal pain, headache, and other symptoms, and it can lead to serious complications if not treated promptly.
Principle: The FactView Typhoid IgG/IgM Rapid Test Kit is an immunochromatographic assay that detects the presence of IgG and IgM antibodies in a patient's blood sample. IgM antibodies are typically produced during the acute phase of infection, while IgG antibodies are produced later during the convalescent phase.
Components: The test kit usually includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antigens for capturing IgG and IgM antibodies against Salmonella typhi.
Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes.
Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of IgG and IgM antibodies against Salmonella typhi. A visible line in the control region indicates that the test is valid. Additional lines in the test region(s) indicate positive results for IgG and/or IgM antibodies.
Sensitivity and Specificity: The FactView Typhoid IgG/IgM Rapid Test Kit demonstrates sensitivity and specificity for detecting typhoid fever. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings.
Utility: The rapid detection of IgG and IgM antibodies against Salmonella typhi provides valuable information for diagnosing acute or recent typhoid fever infections, determining immune status, and guiding patient management decisions.
Limitations: While rapid diagnostic tests are useful for typhoid fever diagnosis, they have limitations compared to more sensitive methods such as blood culture or molecular testing. Factors such as test sensitivity, specificity, and the timing of specimen collection can influence test performance.
Overall, the FactView Typhoid IgG/IgM Rapid Test Kit is an important tool for diagnosing typhoid fever, allowing for timely patient management and implementation of control measures. However, results should be interpreted carefully in conjunction with clinical evaluation and other laboratory tests.
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing. 1.Easy to collect samples simple operation without professional equipment. 2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy. 4.Suitable for large-scale rapid screening. Shelf life: 24 Months Test Result time: 10 Mins Packing: 25 Pieces per Box
CAT No : R0160C. The OnSite Typhoid IgG/IgM Combo Rapid Test is a lateral flow immunoassay for the detection and differentiation of IgG and IgM anti-Salmonella typhi (S. typhi) and paratyphi in human serum, plasma or whole blood. Product Description Utilizes O Antigen And H Antigen From Both Typhi And Paratyphi Serovars To Maximize Sensitivity Differentiates Between Igg And Igm To Determine Stage Of Infection One Step Procedure Minimizes Operator Error Due To Sample Preparation High Level Of Reproducibility Test Kits Can Be Used And Stored In A Wide Range Of Temperatures
Product Details: Number of Reactions(Preps)/Kit : 30T Brand : CTK Biotech Result Time (Rapid Kits) : 15 mins Sample Type : Blood Test Type : Rapid Test CAT No : R0160C The OnSite Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the detection and differentiation of IgG and IgM anti-Salmonella typhi (S. typhi) and paratyphi in human serum, plasma or whole blood. Product Description: Utilizes O Antigen And H Antigen From Both Typhi And Paratyphi Serovars To Maximize Sensitivity Differentiates Between Igg And Igm To Determine Stage Of Infection One Step Procedure Minimizes Operator Error Due To Sample Preparation High Level Of Reproducibility Test Kits Can Be Used And Stored In A Wide Range Of Temperatures Product Specification:- Brand Name : CTK Biotech Pkg Qty : 1 Number Of Items : 30 Specifications : Test Result Within 15 Minutes Allows Medical Professionals To Take Immediate Action Contains1 : Individually Sealed Foil Pouches Containing:One Dip Strip Device,One Desiccant,Plastic Droppers,Sample Diluent (ref Sb-R0160, 5 Ml/Bottle)
CAT No : R0160C. The OnSite Typhoid IgG/IgM Combo Rapid Test is a lateral flow immunoassay for the detection and differentiation of IgG and IgM anti-Salmonella typhi (S. typhi) and paratyphi in human serum, plasma or whole blood. Product Description Utilizes O Antigen And H Antigen From Both Typhi And Paratyphi Serovars To Maximize Sensitivity Differentiates Between Igg And Igm To Determine Stage Of Infection One Step Procedure Minimizes Operator Error Due To Sample Preparation High Level Of Reproducibility Test Kits Can Be Used And Stored In A Wide Range Of Temperatures
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.